Standard steroid treatment for autoimmune pancreatitis

Gut

Volumn 58, Issue 11, 2009, Pages 1504-1507

  Kamisawa, T ^a   Shimosegawa, T ^b   Okazaki, K ^c   Nishino, T ^d   Watanabe, H ^e   Kanno, A ^b   Okumura, F ^f   Nishikawa, T ^g   Kobayashi, K ^h   Ichiya, T ⁱ   Takatori, H ^j   Yamakita, K ^k   Kubota, K ^l   Hamano, H ^m   Okamura, K ⁿ   Hirano, K ^o   Ito, T ^p   Ko, S B H ^q   Omata, M ^o  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g ASAHIKAWA MEDICAL COLLEGE   (Japan)

^h HIROSHIMA UNIVERSITY   (Japan)

ⁱ TEINE KEIJINKAI HOSPITAL   (Japan)

^j KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^k AICHI CANCER CENTER HOSPITAL   (Japan)

^l YOKOHAMA CITY UNIVERSITY   (Japan)

^m SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ Sapporo Kosei General Hospital   (Japan)

^o UNIVERSITY OF TOKYO   (Japan)

^p KYUSHU UNIVERSITY   (Japan)

^q NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; INSULIN; ORAL ANTIDIABETIC AGENT; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; ARTICLE; AUTOIMMUNE PANCREATITIS; AVASCULAR NECROSIS; BILIARY TRACT DRAINAGE; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; JAPAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE JAUNDICE; OSTEOPOROSIS; OUTCOME ASSESSMENT; PANCREAS CANCER; PNEUMONIA; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; REMISSION; RETROPERITONEAL FIBROSIS; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT INDICATION; VERTEBRA FRACTURE;

AUTOIMMUNE DISEASES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PANCREATITIS; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME;

EID: 70350212636     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.172908     Document Type: Article

References (22)

1. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-1568
2. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1-4.
3. Finkelberg DL, Sahani D, Deshpande V, et al. Autoimmune pancreatitis. N Engl J Med 2006;355:2670-2676
4. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006;41:613-625 (Pubitemid 44288524)
5. Kamisawa T, Yoshiike M, Egawa N, et al. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005;5:234-240 (Pubitemid 40754743)
6. Nishino T, Toki F, Oyama H, et al. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006;45:497-501. (Pubitemid 43757352)
7. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007;56:1719-1724 (Pubitemid 350206299)
8. Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc 2007;66:1142-1151 (Pubitemid 350186013)
9. Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol 2007;42(Suppl XVIII):50-58 (Pubitemid 46863938)
10. Kamisawa T, Okamoto A, Wakabayashi T, et al. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastroenterol 2008;43:609-613
11. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008;43:403-408 (Pubitemid 351997876)
12. Ghazale A, Chari S. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007;56:1650-1652 (Pubitemid 350206287)
13. Park DH, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQb1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008;134:440-446
14. Chari ST. Autoimmune pancreatitis, part II: the relapse. Gastroenterology 2008;134:625-628
15. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006;41:626-631 (Pubitemid 44288525)
16. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010-1016 (Pubitemid 44118845)
17. Nishimori I, Tamakoshi A, Kawa S, et al. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis. Findings from a nationwide survey in Japan. Pancreas 2006;32:244-248
18. Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004;99:1605-1616
19. Kamisawa T, Egawa N, Inokuma S, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas 2003;27:235-238 (Pubitemid 37205870)
20. Ito T, Kawabe K, Arita Y, et al. Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas 2007;34:254-259 (Pubitemid 46294803)
21. Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 2004;99:932-937 (Pubitemid 39090226)
22. Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revised. World J Gastroenterol 2006;12:2487-2496